Dr. Anasua Pal is a seasoned life sciences business development professional, with a strong focus on dermatology and immune-mediated diseases. At Symbio, Dr. Pal plays a crucial role in expanding the company’s market presence across the APAC and EMEA regions, identifying and cultivating key collaborations with pharmaceutical and biotech companies and aligning Symbio’s comprehensive CRO services with client needs to drive revenue growth and support therapeutic drug development.
She holds a Ph.D. from the German Cancer Research Center (DKFZ) in Heidelberg, specializing in NK cells. Additionally, she has earned certifications in clinical trial study design and business development. Her specialized training includes immunology, dermatology, B2B sales, and clinical trial analysis.